TipRanks
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
India Market
BALPHARMA
Bal Pharma Limited
RESEARCH TOOLSreports
Want to see IN:BALPHARMA full AI Analyst Report?

Bal Pharma Limited (BALPHARMA) Ratios

0 Followers

Bal Pharma Limited Ratios

IN:BALPHARMA's free cash flow for Q1 2027 was ₹0.20. For the 2027 fiscal year, IN:BALPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.06. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 1.05 1.07 1.15 1.09
Quick Ratio
 0.00 0.59 0.60 0.72 0.62
Cash Ratio
 0.00 0.03 0.04 0.02 <0.01
Solvency Ratio
 -0.23 0.06 0.07 0.07 0.05
Operating Cash Flow Ratio
 0.00 0.06 0.02 0.11 >-0.01
Short-Term Operating Cash Flow Coverage
 0.00 0.11 0.04 0.22 -0.02
Net Current Asset Value
₹ 822.52M₹ -310.54M₹ -234.14M₹ -161.17M₹ -213.14M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.42 0.45 0.45 0.42
Debt-to-Equity Ratio
 0.00 1.94 1.94 2.05 2.09
Debt-to-Capital Ratio
 0.00 0.66 0.66 0.67 0.68
Long-Term Debt-to-Capital Ratio
 0.00 0.28 0.29 0.34 0.32
Financial Leverage Ratio
 0.00 4.57 4.34 4.61 4.91
Debt Service Coverage Ratio
 2.03 0.24 0.25 0.26 0.20
Interest Coverage Ratio
 1.30 1.24 1.17 1.41 1.67
Debt to Market Cap
 0.00 1.66 1.15 0.96 1.25
Interest Debt Per Share
 10.82 110.85 114.71 105.26 91.59
Net Debt to EBITDA
 0.00 4.50 4.48 4.31 5.37
Profitability Margins
Gross Profit Margin
29.10%24.43%24.09%22.70%41.24%
EBIT Margin
6.98%7.30%7.26%6.47%5.05%
EBITDA Margin
10.37%10.85%10.48%9.44%8.05%
Operating Profit Margin
6.71%6.68%6.53%6.33%5.83%
Pretax Profit Margin
2.05%1.90%1.70%2.67%1.56%
Net Profit Margin
2.15%2.02%2.38%2.18%0.85%
Continuous Operations Profit Margin
2.17%2.03%2.39%2.19%0.86%
Net Income Per EBT
105.00%105.89%140.45%81.71%54.16%
EBT Per EBIT
30.57%28.50%25.96%42.16%26.79%
Return on Assets (ROA)
0.00%1.67%2.15%2.31%0.82%
Return on Equity (ROE)
8.98%7.64%9.32%10.67%4.03%
Return on Capital Employed (ROCE)
0.00%16.49%17.03%18.42%17.07%
Return on Invested Capital (ROIC)
0.00%8.20%8.39%7.99%4.76%
Return on Tangible Assets
0.00%1.75%2.26%2.43%0.86%
Earnings Yield
4.46%6.54%5.51%5.10%2.44%
Efficiency Ratios
Receivables Turnover
 0.00 3.29 3.24 3.41 3.12
Payables Turnover
 0.00 2.65 2.97 3.38 2.19
Inventory Turnover
 0.00 2.02 2.36 2.99 1.76
Fixed Asset Turnover
 0.00 3.70 4.11 5.28 4.89
Asset Turnover
 0.00 0.83 0.90 1.06 0.97
Working Capital Turnover Ratio
 51.42 21.97 13.04 13.59 16.12
Cash Conversion Cycle
 0.00 153.47 144.76 121.60 157.29
Days of Sales Outstanding
 0.00 111.02 112.69 107.19 116.97
Days of Inventory Outstanding
 0.00 180.33 154.85 122.24 207.05
Days of Payables Outstanding
 0.00 137.89 122.78 107.84 166.74
Operating Cycle
 0.00 291.35 267.54 229.43 324.02
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 9.10 2.90 15.24 -1.17
Free Cash Flow Per Share
 0.00 -2.57 -9.98 7.90 -10.51
CapEx Per Share
 0.00 11.66 12.88 7.34 9.33
Free Cash Flow to Operating Cash Flow
 0.00 -0.28 -3.44 0.52 8.94
Dividend Paid and CapEx Coverage Ratio
 0.00 0.71 0.20 1.82 -0.11
Capital Expenditure Coverage Ratio
 0.00 0.78 0.23 2.08 -0.13
Operating Cash Flow Coverage Ratio
 0.00 0.09 0.03 0.16 -0.01
Operating Cash Flow to Sales Ratio
 0.00 0.05 0.01 0.07 >-0.01
Free Cash Flow Yield
0.00%-4.25%-11.11%8.16%-15.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 22.35 15.30 19.70 19.60 40.91
Price-to-Sales (P/S) Ratio
 0.48 0.31 0.43 0.43 0.35
Price-to-Book (P/B) Ratio
 1.96 1.17 1.69 2.09 1.65
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -23.54 -9.00 12.25 -6.38
Price-to-Operating Cash Flow Ratio
 0.00 6.64 30.95 6.35 -57.07
Price-to-Earnings Growth (PEG) Ratio
 -3.61 -1.14 -6.61 0.11 -0.72
Enterprise Value Multiple
 4.66 7.34 8.61 8.83 9.67
Enterprise Value
 1.62B 2.48B 2.73B 2.83B 2.37B
EV to EBITDA
 4.66 7.34 8.61 8.83 9.67
EV to Sales
 0.48 0.80 0.90 0.83 0.78
EV to Free Cash Flow
 0.00 -60.84 -18.78 23.92 -14.36
EV to Operating Cash Flow
 0.00 17.17 64.59 12.40 -128.45
Tangible Book Value Per Share
 51.66 40.86 42.23 36.12 31.50
Shareholders’ Equity Per Share
 51.66 51.69 53.09 46.31 40.66
Tax and Other Ratios
Effective Tax Rate
 -0.06 -0.07 -0.41 0.18 0.45
Revenue Per Share
 210.04 195.91 207.85 226.69 193.89
Net Income Per Share
 4.53 3.95 4.95 4.94 1.64
Tax Burden
 1.05 1.06 1.40 0.82 0.54
Interest Burden
 0.29 0.26 0.23 0.41 0.31
Research & Development to Revenue
 0.00 0.00 0.01 0.01 0.02
SG&A to Revenue
 0.17 0.18 0.18 0.01 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 2.30 0.59 3.09 -0.39
Currency in INR